Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for trametinib

Release date: 2024-07-10 15:15:34     Recommended: 139

09L1019_23 恩西地平 批文_00.jpg

This drug is an oral tablet that can be used to treat unresectable or metastatic melanoma with BRAF (mouse sarcoma filtering toxin oncogenic homolog B1 gene) V600E or V600K mutations, but it is not recommended for patients who have already received BRAF inhibitor treatment.

Company News

Research News

Drug news